annual EBITDA:
-$266.36M-$31.00M(-13.17%)Summary
- As of today (September 19, 2025), VRDN annual EBITDA is -$266.36 million, with the most recent change of -$31.00 million (-13.17%) on December 31, 2024.
- During the last 3 years, VRDN annual EBITDA has fallen by -$187.07 million (-235.94%).
- VRDN annual EBITDA is now -543497.96% below its all-time high of -$49.00 thousand, reached on December 31, 2013.
Performance
VRDN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$106.45M-$12.90M(-13.79%)Summary
- As of today (September 19, 2025), VRDN quarterly EBITDA is -$106.45 million, with the most recent change of -$12.90 million (-13.79%) on June 30, 2025.
- Over the past year, VRDN quarterly EBITDA has dropped by -$34.81 million (-48.59%).
- VRDN quarterly EBITDA is now -256615.66% below its all-time high of $41.50 thousand, reached on December 31, 2013.
Performance
VRDN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$370.50M-$34.81M(-10.37%)Summary
- As of today (September 19, 2025), VRDN TTM EBITDA is -$370.50 million, with the most recent change of -$34.81 million (-10.37%) on June 30, 2025.
- Over the past year, VRDN TTM EBITDA has dropped by -$121.29 million (-48.67%).
- VRDN TTM EBITDA is now -570781.36% below its all-time high of -$64.90 thousand, reached on December 31, 2013.
Performance
VRDN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VRDN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.2% | -48.6% | -48.7% |
| 3 y3 years | -235.9% | -262.0% | -279.6% |
| 5 y5 years | -553.6% | -1649.5% | -955.6% |
VRDN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -235.9% | at low | -262.0% | at low | -279.6% | at low |
| 5 y | 5-year | -553.6% | at low | -1983.3% | at low | -1175.5% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
VRDN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$106.45M(+13.8%) | -$370.50M(+10.4%) |
| Mar 2025 | - | -$93.55M(+7.1%) | -$335.69M(+12.8%) |
| Dec 2024 | -$266.36M(+13.2%) | -$87.35M(+5.0%) | -$297.70M(+5.8%) |
| Sep 2024 | - | -$83.15M(+16.1%) | -$281.48M(+12.9%) |
| Jun 2024 | - | -$71.64M(+29.0%) | -$249.22M(+5.4%) |
| Mar 2024 | - | -$55.55M(-21.9%) | -$236.41M(-6.6%) |
| Dec 2023 | -$235.37M(+82.3%) | -$71.13M(+39.8%) | -$253.13M(+9.6%) |
| Sep 2023 | - | -$50.89M(-13.5%) | -$230.87M(+28.3%) |
| Jun 2023 | - | -$58.84M(-18.6%) | -$179.98M(+19.6%) |
| Mar 2023 | - | -$72.27M(+47.9%) | -$150.54M(+44.7%) |
| Dec 2022 | -$129.13M(+62.9%) | -$48.87M(+66.2%) | -$104.03M(+6.6%) |
| Jun 2022 | - | -$29.41M(+14.2%) | -$97.61M(+13.4%) |
| Mar 2022 | - | -$25.75M(-9.5%) | -$86.08M(+9.4%) |
| Dec 2021 | -$79.29M(-27.9%) | -$28.45M(+103.1%) | -$78.71M(+11.0%) |
| Sep 2021 | - | -$14.00M(-21.6%) | -$70.94M(+14.3%) |
| Jun 2021 | - | -$17.87M(-2.8%) | -$62.04M(+23.5%) |
| Mar 2021 | - | -$18.38M(-11.1%) | -$50.26M(+26.5%) |
| Dec 2020 | -$109.97M(+169.9%) | -$20.68M(+304.7%) | -$39.73M(+36.8%) |
| Sep 2020 | - | -$5.11M(-16.0%) | -$29.05M(-17.2%) |
| Jun 2020 | - | -$6.08M(-22.5%) | -$35.10M(-7.4%) |
| Mar 2020 | - | -$7.86M(-21.4%) | -$37.88M(-9.1%) |
| Dec 2019 | -$40.75M | -$10.00M(-10.4%) | -$41.69M(-0.9%) |
| Sep 2019 | - | -$11.16M(+25.8%) | -$42.07M(+5.3%) |
| Jun 2019 | - | -$8.87M(-23.9%) | -$39.96M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.66M(+12.4%) | -$39.85M(+21.7%) |
| Dec 2018 | -$31.55M(+22.2%) | -$10.38M(+14.7%) | -$32.74M(+14.3%) |
| Sep 2018 | - | -$9.05M(+3.3%) | -$28.64M(+12.9%) |
| Jun 2018 | - | -$8.76M(+92.5%) | -$25.37M(+6.3%) |
| Mar 2018 | - | -$4.55M(-27.5%) | -$23.86M(-8.8%) |
| Dec 2017 | -$25.82M(+108.4%) | -$6.27M(+8.4%) | -$26.18M(+1.7%) |
| Sep 2017 | - | -$5.79M(-20.2%) | -$25.73M(+7.6%) |
| Jun 2017 | - | -$7.25M(+5.6%) | -$23.92M(+25.2%) |
| Mar 2017 | - | -$6.87M(+17.9%) | -$19.11M(+28.0%) |
| Dec 2016 | -$12.39M(+12.6%) | -$5.83M(+46.3%) | -$14.93M(+24.3%) |
| Sep 2016 | - | -$3.98M(+63.5%) | -$12.02M(+8.1%) |
| Jun 2016 | - | -$2.44M(-9.4%) | -$11.12M(-0.1%) |
| Mar 2016 | - | -$2.69M(-7.6%) | -$11.12M(+1.1%) |
| Dec 2015 | -$11.00M(+63.7%) | -$2.91M(-5.6%) | -$11.00M(+5.7%) |
| Sep 2015 | - | -$3.08M(+26.0%) | -$10.41M(+16.6%) |
| Jun 2015 | - | -$2.44M(-4.8%) | -$8.93M(+37.7%) |
| Mar 2015 | - | -$2.57M(+10.7%) | -$6.48M(+65.5%) |
| Dec 2014 | -$6.72M(>+9900.0%) | -$2.32M(+45.0%) | -$3.92M(+151.5%) |
| Sep 2014 | - | -$1.60M(-3952.8%) | -$1.56M(+2299.7%) |
| Dec 2013 | -$49.00K(-98.7%) | $41.50K(-139.0%) | -$64.90K(-79.6%) |
| Sep 2013 | - | -$106.40K(-49.9%) | -$318.60K(-58.0%) |
| Dec 2012 | -$3.88M | - | - |
| Dec 2012 | - | -$212.20K(-61.2%) | -$758.80K(+38.8%) |
| Sep 2012 | - | -$546.60K | -$546.60K |
FAQ
- What is Viridian Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Viridian Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Viridian Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of VRDN is -$266.36M
What is the all time high annual EBITDA for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual EBITDA is -$49.00K
What is Viridian Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, VRDN annual EBITDA has changed by -$31.00M (-13.17%)
What is Viridian Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of VRDN is -$106.45M
What is the all time high quarterly EBITDA for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly EBITDA is $41.50K
What is Viridian Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, VRDN quarterly EBITDA has changed by -$34.81M (-48.59%)
What is Viridian Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of VRDN is -$370.50M
What is the all time high TTM EBITDA for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM EBITDA is -$64.90K
What is Viridian Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, VRDN TTM EBITDA has changed by -$121.29M (-48.67%)